Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2003-06-23
2008-12-30
Kim, Young J (Department: 1637)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100, C435S091200, C536S023100, C536S024300, C536S024330
Reexamination Certificate
active
07470512
ABSTRACT:
The present invention describes oligonucleotides targeted to HPV Type 16 and/or Type 18 nucleic acid sequences which are particularly useful to aid in detecting HPV type 16 and or 18. The oligonucleotides can aid in detecting HPV Type 16 and/or Type 18 in different ways such as by acting as hybridization assay probes, helper probes, and/or amplification primers.
REFERENCES:
patent: 4886741 (1989-12-01), Schwartz
patent: 4983728 (1991-01-01), Herzog et al.
patent: 5030557 (1991-07-01), Hogan et al.
patent: 5079351 (1992-01-01), Sninsky et al.
patent: 5182377 (1993-01-01), Manos et al.
patent: 5185439 (1993-02-01), Arnold et al.
patent: 5283171 (1994-02-01), Manos et al.
patent: 5399491 (1995-03-01), Kacian et al.
patent: 5474796 (1995-12-01), Brennan
patent: 5484699 (1996-01-01), Bouma et al.
patent: 5501947 (1996-03-01), Emery et al.
patent: 5597910 (1997-01-01), Gudibande et al.
patent: 5871975 (1999-02-01), Kacian et al.
patent: 2002775 (1990-05-01), None
patent: 3838269 (1990-05-01), None
patent: 4431 174 (1996-03-01), None
patent: 0402132 (1980-12-01), None
patent: 0313219 (1989-04-01), None
patent: 0 402 132 (1990-06-01), None
patent: 0 477 972 (1991-09-01), None
patent: 0477972 (1992-04-01), None
patent: 0489442 (1992-06-01), None
patent: 0524807 (1993-01-01), None
patent: 0630973 (1994-12-01), None
patent: 2 679 254 (1991-07-01), None
patent: 05 192200 (1993-08-01), None
patent: 8803957 (1988-06-01), None
patent: 88/66347 (1988-09-01), None
patent: 8806634 (1988-09-01), None
patent: 8902934 (1989-04-01), None
patent: 8909940 (1989-10-01), None
patent: 9002821 (1990-03-01), None
patent: 9004790 (1990-05-01), None
patent: 9108312 (1991-06-01), None
patent: 9110675 (1991-07-01), None
patent: 94/01815 (1992-02-01), None
patent: 9201815 (1992-02-01), None
patent: 9214847 (1992-09-01), None
patent: 9302217 (1993-02-01), None
patent: 93/12245 (1993-06-01), None
patent: 94/26934 (1994-11-01), None
patent: WO 95/28942 (1995-11-01), None
patent: 9606950 (1996-03-01), None
Dopazo et al (J. Virol. Meth. (1993) 41:157-165).
Tyan et al (J. Clin Microbiol. (1993) 31(1) :53-56).
Paper, et al., “Use of sulfonated primers to detect and type papillomavirus in cell cultures and cervical biopsies,”Gene155-161 (1991).
Paper, et al., “Use of sulfonated primers to detect and type papillomavirus in cell cultures and cervical biopsies,”Gene103: 155-161 (1991).
Baker et al., “Structural and Transcriptional Analysis of Human Papillomavirus Type 16 Sequences in Cervical Carcinoma Cell Lines,”J. of Virology61(4):962-971 (1987).
Barone et al., “In situ activities of bis-dialkylaminophosphines—a new method for synthesizing deoxyoligonucleotides on polymers supports,”Nucleic Acids Research12:4051-4061 (1984).
Broker et al., “Symposium 7: Papillomaviruses and Human Cancer,”Proc. of the Am. Assoc. for Cancer Research, 31:488-490 (Mar. 1990).
Chow et al., “Human Papillomavirues Gene Expression,” inCancer Cells, Cold Spring Harbor Laboratory, 5:55-71 (1987).
Cone et al., “Conservation of HPV-16 E6/E7 ORF Sequences in a Cervical Carcinoma,”J. of Medical Virology37:99-107 (1992).
Cornelissen et al., “Uniformity of the splicing pattern of the E6/E7 transcripts in human papillomavirus type 16-transformed human fibroblasts, human cervical premalignant lesions and carcinomas,”J. Gen. Virol. 71:1243-1246 (1990).
Cossman et al., “Ch. 19—Detection of Human Papillomavirus Infection,” inMolecular Genetics in Cancer Diagnosis,Elsevier, New York, pp. 331-348 (1990).
Costa et al., “Is Vestibular Papillomatosis Associated With Human Papillomavirus?”J. of Medical Virology, 35:7-13 (1991).
Crum et al., “Coexpression of the Human Papillomavirus Type 16 E4 and L1 Open Reading Frames in Early Cervical Neoplasia,”Virology, 178:238-246 (1990).
Crum, “Identifying High-Risk Precursors of Cervical Cancer,”Am.J. Clin. Pathology92(3):379-382 (1989).
Crum et al., “Pathobiology of Papillomavirus-Related Cervical Diseases: Prospects for Immunodiagnosis,”Clinical Microbiology Reviews4(3):270-285 (1991).
Czegledy et al., “Detection of Human Papillomavirus Deoxyribonucleic Acid Filter in Site Hybridization During Pregnancy,”J. of Med. Virology28:250-254 (1989).
De Britton et al., “Human Papillomaviruses and Other Influences on Survival From Cervical Cancer in Panama,”Obstetrics and Gynecology81:19-24 (1993).
Doeberitz et al., “Growth-regulating Functions of Human Papillomavirus Early Gene Products in Cervical Cancer Cells Acting Dominant over Enhanced Epidermal Growth Factor Receptor Expression,”Cancer Res. 50:3730-3736 (1990).
Doeberitz et al., “Correlation of Modified Human Papilloma Virus Early Gene Expression with Altered Growth Properties in C4-L Cervical Carcinoma Cells,”Cancer Res. 48:3780-3786 (1988).
Doeberitz et al., “Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells,”Medical Sciences88:1411-1415 (1991).
Doorbar et al., “Detection of Novel Splicing Patterns in a HPV16-Containing Keratinocyte Cell Line,”Virology178:254-262 (1990).
Durst et al., “Inverse Relationship between Human Papillomavirus (HPV) Type 16 Early Gene Expression and Cell Differentiation in Nude Mouse Epithelial Cysts and Tumors Induced by HPV-Positive Human Cell Lines,”J. of Virology65(1):796-804 (1991).
Ensser et al., “Epidermodysplasia verruciformis associated human papillomaviruses present a subgenus-specific organization of the regulatory genomic region,”Nucleic Acids Res. 18(13):3919-3922 (1990).
Evander et al., “Oligonucleotide primers for DNA amplification of the early regions 1, 6, and 7 form human papillomavirus types 6, 11, 16, 18, 31, and 33,”Arch. Virol. 116:221-233 (1991).
Fackelmann, “Deadly duo leads to cancer of the cervix,”Science News14:38 (1993).
Falcinelli et al., “Detection of the Human Papilloma Virus Type 16 mRNA-Transcripts in Cytological Abnormal Scrapings,”J. of Medical Virology37:93-98 (1992).
Firzlaff et al., “Detection of Human Papillpmavirus Capsid Antigens in Various Squamous Epithelial Lesions Using Antibodies Directed against the L1 and L2 Open Reading Frames,”Virology164:467-477 (1988).
Garuti et al., “Prevalence of different types of human papillomavirus in cervical infection of North Italian woman,”European J. of Obstetrics&Gynecology and Reproductive Biology39:227-233 (1991).
Gius et al., “Inducible and Constitutive Enhancer Domains in the Noncoding Region of Human Papillomavirus Type 18,”J. of Virology62(3):665-672 (1988).
Gradus et al., “Significance of Human Papillomavirus (HPV) Infection in a Sexually Transmitted Disease (STD) Clinic,” Abstracts of the General Mcetinf, 408 at abstract No. C-396 (1991).
Gravitt and Manos, “Polymerase chain reaction-based methods for the detection of human papillomavirus DNA,” inThe Epidemiology of Cervical Cancer and Human Papillomavirus, edited by Munoz et al., International Agency for Research on Cancer, pp. 121-133 (1992).
Heilman et al., “Virus-Specific Transcription in Bovine Papillomavirus-Transformed Mouse Cells,”Virology119:22-34 (1982).
Higgins et al., “Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA,”The Lancet338:910-913 (1991).
Higgins et al., “Differing Characteristics of Human Papillomavirus RNA-Positive and RNA-Negative Anal Carcinomas,”Cancer68(3):561-567 (1991).
Horn et al., “Genital Human Papillomavirus Infections in Patients Attending an Inner-City STD Clinic,”Sexually Transmitted Diseases18(3):183-187 (1991).
Howley et al., “Ch. 58—Papillomaviriuse and Their Replication,”Virology, Second Edition, edited by Fields et
Brentano Steven T.
Carter Nick M.
Gordon Patricia
Hammond Philip W.
Cappellari Charles B.
Gen-Probe Incorporated
Gritzmacher Christine A.
Heber Sheldon O.
Kim Young J
LandOfFree
Oligonucleotides for use in determining the presence of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligonucleotides for use in determining the presence of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotides for use in determining the presence of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4043295